Capital International Investors Portfolio holdings
Capital International, established in 1968 as a division of the Los Angeles-based Capital Group, is a global investment management firm focused on delivering equity investment solutions for institutional and individual clients worldwide. Operating as part of one of the oldest and largest asset managers, founded in 1931, it leverages Capital Group’s signature research-driven, long-term investment philosophy, managing billions in assets through a multi-manager system that diversifies risk and enhances performance. Headquartered in Los Angeles with a presence across North America, Europe, and Asia, Capital International specializes in international and global equity strategies, often through mutual funds like those in the American Funds family. Known for its rigorous fundamental analysis and commitment to client outcomes, it plays a key role in Capital Group’s mission to provide consistent, superior returns in global markets.
Top Buys
| 1 |
AbbVie
ABBV
|
+$1.94B |
| 2 |
Bristol-Myers Squibb
BMY
|
+$1.17B |
| 3 |
Albemarle
ALB
|
+$694M |
| 4 |
VICI Properties
VICI
|
+$599M |
| 5 |
FRC
First Republic Bank
FRC
|
+$576M |
Top Sells
| 1 |
Eli Lilly
LLY
|
+$1.26B |
| 2 |
Netflix
NFLX
|
+$822M |
| 3 |
Meta Platforms (Facebook)
META
|
+$729M |
| 4 |
EOG Resources
EOG
|
+$712M |
| 5 |
Truist Financial
TFC
|
+$656M |
Sector Composition
| 1 | Technology | 20.46% |
| 2 | Healthcare | 16.89% |
| 3 | Financials | 14.17% |
| 4 | Communication Services | 10.18% |
| 5 | Industrials | 9.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
276
Cenovus Energy
CVE
$30.4B
| $125M | 0.03% |
6,570,800
+6,000,000
| +1,051% | +$114M |
|
277
Fabrinet
FN
$12.8B
| $124M | 0.03% |
1,530,065
+201
| +0% | +$16.3K |
|
278
Toll Brothers
TOL
$13.8B
| $124M | 0.03% |
2,781,997
+669,335
| +32% | +$29.9M |
|
279
TotalEnergies
TTE
$133B
| $124M | 0.03% |
2,336,956
+239,325
| +11% | +$12.7M |
|
280
Novanta
NOVT
$4.12B
| $123M | 0.03% |
1,015,687
| – | – |
|
281
Ryan Specialty Holdings
RYAN
$6.61B
| $123M | 0.03% |
3,139,432
| – | – |
|
282
Baxter International
BAX
$12.3B
| $122M | 0.03% |
1,895,696
| – | – |
|
283
Ascendis Pharma
ASND
$11.8B
| $122M | 0.03% |
1,307,021
+1,060,819
| +431% | +$98.6M |
|
284
Enpro
NPO
$4.64B
| $117M | 0.03% |
1,432,727
| – | – |
|
285
HDFC Bank
HDB
$179B
| $117M | 0.03% |
2,120,428
+156,630
| +8% | +$8.66M |
|
286
Bunge Global
BG
$16.3B
| $111M | 0.03% |
+1,225,418
| New | +$111M |
|
287
Corpay
CPAY
$21.7B
| $111M | 0.03% |
527,656
+2,380
| +0.5% | +$500K |
|
288
Celsius Holdings
CELH
$14.9B
| $110M | 0.03% |
5,058,033
| – | – |
|
289
Lowe's Companies
LOW
$152B
| $110M | 0.03% |
627,754
+11,967
| +2% | +$2.09M |
|
290
Caesars Entertainment
CZR
$5.22B
| $109M | 0.03% |
2,850,260
-2,114,823
| -43% | -$81M |
|
291
Global Payments
GPN
$20.7B
| $109M | 0.03% |
980,874
+5,054
| +0.5% | +$559K |
|
292
Kadant
KAI
$3.69B
| $103M | 0.03% |
567,165
| – | – |
|
293
Incyte
INCY
$16.2B
| $101M | 0.03% |
1,326,398
-70,867
| -5% | -$5.38M |
|
294
Endava
DAVA
$537M
| $98.6M | 0.03% |
1,116,597
+232
| +0% | +$20.5K |
|
295
HUTCHMED
HCM
$3.08B
| $98.2M | 0.03% |
7,765,939
-1,339,164
| -15% | -$16.9M |
|
296
TELUS International
TIXT
$1.25B
| $95.6M | 0.03% |
3,814,652
-1,721,465
| -31% | -$43.2M |
|
297
NetEase
NTES
$96.8B
| $95.3M | 0.03% |
1,023,989
-23,638
| -2% | -$2.2M |
|
298
Regal Rexnord
RRX
$9.22B
| $94.5M | 0.03% |
832,445
-4,297
| -0.5% | -$488K |
|
299
STMicroelectronics
STM
$23.1B
| $94.4M | 0.03% |
2,929,472
+71,906
| +3% | +$2.32M |
|
300
CoStar Group
CSGP
$36.8B
| $92.7M | 0.03% |
1,535,026
+5,331
| +0.3% | +$322K |
|